Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma-Reference-Cited by-同舟云学术

Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma

Published:2020-03-18 Issue:12 Volume:126 Page:2775-2783
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Russo Mariano¹²,Newell Jordan M.³,Budurlean Laura¹²^ORCID,Houser Kenneth R.¹²,Sheldon Kathryn¹²,Kesterson Joshua⁴,Phaeton Rebecca⁴,Hossler Carrie⁴,Rosenberg Jennifer⁵,DeGraff David³,Shuman Lauren³,Broach James R.¹²,Warrick Joshua I.³^ORCID

Affiliation:

1. Department of Biochemistry Penn State College of Medicine Penn State Health Hershey Pennsylvania

2. Institute for Personalized Medicine Penn State College of Medicine Penn State Health Hershey Pennsylvania

3. Department of Pathology Penn State College of Medicine Penn State Health Hershey Pennsylvania

4. Department of Obstetrics and Gynecology Penn State College of Medicine Penn State Health Hershey Pennsylvania

5. Department of Radiation Oncology Penn State College of Medicine Penn State Health Hershey Pennsylvania

Funder

Pennsylvania Department of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32822

Reference40 articles.

1. Cancer statistics, 2019

2. Endometrial adenocarcinoma

3. Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer

4. Molecular identification of latent precancers in histologically normal endometrium;Mutter GL;Cancer Res,2001

5. Adenocarcinoma of the Uterine Corpus

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometrial hyperplasia and endometrial polyps: clinical and anamnestic characteristics of women;Fundamental and Clinical Medicine;2024-01-02

2. Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics?;Cancers;2023-12-29

3. The role and participation of immune cells in the endometrial tumor microenvironment;Pharmacology & Therapeutics;2023-11

4. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient;Molecular Case Studies;2023-10-17

5. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome;Modern Pathology;2023-07